Search

You searched for "infection"

2992 results found

Chanter Biomed appointed as new UK distributor & service company for Entermed

5 September 2022 | Company Profiles, Contracts & Distributors
Chanter Biomed are pleased to announce that they’ve been appointed as new UK distributor and service company for Entermed ENT equipment. Engineers have already travelled to Entermed’s headquarters in the Netherlands for product training, which included ENT units, scopes, chairs and electrosurgical equipment.
Otolaryngologic Clinics front cover image

Advances in neural stimulation of the auditory pathway

7 July 2020 | | ENTA-Auditory Implants | Neural stimulation techniques, Neuroprosthetics, Optogenetics, Sensory disorders
This article reviews the use of neuroprosthetic devices such as cochlear and auditory brainstem implants (ABI) to stimulate the auditory pathway, discussing the successes, limitations and advances in this area. Currently, neuroprosthetic devices deliver electrical impulses to the cochlear nerve...

Cochlear implantation in adults has a positive impact on overall cognitive function as early as six months postop

30 April 2020 | | Neurotology, Otology
The link between improving hearing and thus improving cognition is an important emerging area of research in hearing rehabilitation, due to the independent association between hearing loss and dementia. This study uses visually assessed neurocognitive tests of working memory, information...

Should we be doing earlier MRIs in sudden sensorineural hearing loss?

7 January 2020 | | ENTA-Head & Neck, ENTA-Rhinology / Sinus
There is recognised variation between ENT departments in exact imaging protocols for the workup of idiopathic sudden sensorineural hearing loss (ISSNHL) but a routine MRI to exclude retrocochlear pathology is standard, usually following immediate treatment with oral +/- intratympanic steroids....

FDA grants Lenire tinnitus treatment device De Novo approval

15 March 2023 | Company Profiles, Research & Development
Neuromod Devices Ltd. is proud to announce that the US Food and Drug Administration (FDA) has granted De Novo approval to Lenire.

New patient education infographic from Cl-ear™

17 April 2023 | Research & Development
According to research into the nation’s hearing health habits commissioned by Cl-ear™, the fastest growing OTC ear care range¹, DIY ear wax removal is rife.

Leading in cochlear implant reliability

27 April 2023 | Company Profiles, Research & Development
All MED-EL’S titanium cochlear implants since 2006 have an overall cumulative survival rate of over 99%.

Carleton Introduce New 445nm Blue Laser

8 June 2023 | Research & Development, Contracts & Distributors
Carleton Medical are the new UK distributor for the BlueScan ENT 445nm Laser from manufacturer InterMedic.

Otovent new app launched – come and explore Otopia!

8 June 2023 | Contracts & Distributors, Research & Development
Otovent proudly launches their new fun, easy to use app to help track Otovent use.

Minimise waiting times with Peptest!

3 July 2023 | Research & Development
In laryngopharyngeal reflux (LPR), refluxed stomach contents travel up the oesophagus and reach the larynx, causing chronic extra-gastrointestinal symptoms such as a persistent cough, hoarseness or difficulty swallowing, meaning it is often attributed to ENT problems.

Neuromod Devices’ €30m funding powers Lenire expansion

31 August 2023 | Company Profiles, Research & Development
Neuromod Devices, the global technology business behind scientifically proven tinnitus treatment technology, Lenire, closed €30m funding to expand availability of the groundbreaking tinnitus intervention.

VACANCY: Lecturer/Senior Lecturer in Audiology

4 September 2023 | Recruitment & Personnel
You would work as part of a team and primarily deliver high quality teaching and training across a range of programmes based on your area of specialism